This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
See you next year! September 15 -18, 2025
Hynes Convention CenterBoston, USA

Elisabeth Krug, PhD
Executive Director, BRD Analytical Development at Eli Lilly & Company
Speaker

Profile

Dr. Elisabeth Krug graduated from the University of Würzburg, Germany, in 1994 as a pharmaceutical biologist. She started with Lilly in 1995 as an analytical scientist in the small molecule development. She then took an assignment in Six Sigma becoming a Master Black Belt. Since 2010, Dr. Krug has been extensively working with biomolecules, where she is responsible to support the analytical development and control strategy definition for biomolecules.

Agenda Sessions

  • Platform Analytical Procedures - Applying Concepts in ICH Q2(R2) and ICH Q14

    11:30am

At this event